← Leaderboards
Omid C Farokhzad
Brigham And Women'S Hospital
$3,124,108
Attributed
$5,284,056
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $769.3K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,284,056 · 3
By mechanism
R01$4,319,896 · 2
K08$964,160 · 1
Top collaborators
- Rohit N Karnik4 shared
- Ira A Tabas2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jeffrey Michael Karp$7,701,091
- Timothy T Kuo$681,370
- Edward P Ingenito$10,382,683
- Chandrajit Premanand Raut$1,499,012
- Sushrut S. Waikar$14,689,878
Others in their field
Top investigators on “Encapsulated”
- Holly Janes · Fred Hutchinson Cancer Center$52,003,716
- Peter B. Gilbert · Fred Hutchinson Cancer Center$52,003,716
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Barton F Haynes · Duke University$41,694,831
- Howard Y Chang · Stanford University$19,041,047
- Daniel Edward Lee Promislow · University Of Georgia (Uga)$17,959,587
Research focus
EncapsulatedMediatingNanoparticleCopolymerExtracellularAffinityTechnologyNucleic AcidsProteinsBinding (Molecular Function)Malignant NeoplasmsIn VitroAntibodiesIn VivoEffectivenessPoly(Lactic Acid)Mouse ModelAreaFutureLigandsDesignDoseDensityDrug Delivery Systems
Grant awards (11)
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics$746,562
R01 · FY2017 · HL
Enhancing Inflammation Resolution in Atherosclerosis via Targeted Nanoparticle-Mediated Delivery of Biologics$769,326
R01 · FY2016 · HL
Development of FcRn-Targeted Nanoparticles for Efficient Oral Delivery of Insulin$672,282
R01 · FY2015 · EB · contact PI
Development of FcRn-Targeted Nanoparticles for Efficient Oral Delivery of Insulin$684,066
R01 · FY2014 · EB · contact PI
Development of FcRn-Targeted Nanoparticles for Efficient Oral Delivery of Insulin$682,868
R01 · FY2013 · EB · contact PI
Development of FcRn-Targeted Nanoparticles for Efficient Oral Delivery of Insulin$764,792
R01 · FY2012 · EB · contact PI
Development of Disease-Specific Drug Delivery Vehicles$192,888
K08 · FY2009 · EB · contact PI
Development of Disease-Specific Drug Delivery Vehicles$192,888
K08 · FY2008 · EB · contact PI
Development of Disease-Specific Drug Delivery Vehicles$192,888
K08 · FY2007 · EB · contact PI
Development of Disease-Specific Drug Delivery Vehicles$192,888
K08 · FY2006 · EB · contact PI
Development of Disease-Specific Drug Delivery Vehicles$192,608
K08 · FY2005 · EB